CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Helixmith Co Ltd (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Helixmith Co Ltd (Parent)
21, Magokjungang 8-ro 7-gil, Gangseo-gu
Phone: +82 221027200p:+82 221027200 SEOUL, 07794  South Korea Fax: +82 28870011f:+82 28870011
Business Summary
Helixmith Co Ltd, formerly ViroMed Co Ltd, is a Korea-based company mainly engaged in the development and sales of natural medicines and health functional foods. The Company operates its business through two segments. The Natural Products Business segment develops and sells raw materials for functional materials and health functional foods such as Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment develops diabetic neuropathy treatment, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis treatment, ischemic heart disease, and anticancer treatment.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201412/31/2014Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Won HoPark 64 8/1/2021 4/1/2021
Chief Executive Officer, Director Bu HyeokYoon 58 3/15/2023 3/15/2023
Chief Financial Officer Hyeong JunKim 3/15/2023 3/15/2023
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 54 (As of 12/31/2013)
Outstanding Shares: 41,550,620 (As of 3/10/2023)
Shareholders: 3,844
Fax Number: +82 28870011


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023